Danaher Corp (DHR)
228.55
+2.39
(+1.06%)
USD |
NYSE |
Dec 20, 16:00
228.98
+0.43
(+0.19%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 165.08B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 1.19% |
| Valuation | |
| PE Ratio | 43.62 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 7.139 |
| Price to Book Value | 3.218 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.27 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.3416 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 36.59% |
Profile
| In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto. |
| URL | https://www.danaher.com |
| Investor Relations URL | https://investors.danaher.com/ |
| HQ State/Province | District of Columbia |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Jan. 30, 2025 (est.) |
| Last Earnings Release | Oct. 22, 2024 |
| Next Ex-Dividend Date | Dec. 27, 2024 |
| Last Ex-Dividend Date | Sep. 27, 2024 |
Ratings
Profile
| In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto. |
| URL | https://www.danaher.com |
| Investor Relations URL | https://investors.danaher.com/ |
| HQ State/Province | District of Columbia |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Jan. 30, 2025 (est.) |
| Last Earnings Release | Oct. 22, 2024 |
| Next Ex-Dividend Date | Dec. 27, 2024 |
| Last Ex-Dividend Date | Sep. 27, 2024 |